Skip to main content
Premium Trial:

Request an Annual Quote

Compugen to Lead $3.7M EC-Funded MAP-Kinase Pathway Consortium

NEW YORK, March 7 (GenomeWeb News) - Compugen announced today it is leading an international consortium to develop a platform to simulate the MAP-kinase pathway.


The European Commission is funding the consortium with €3.1 million ($3.7 million) over three years.


Other consortium members include Aureus Pharma, Consejo Superior de Investigaciones Cientificas, Institut De Recerca Hospital Universitari Vall De Hebron, Instituto Nazionale Tumori, Max Planck Institute for Infection Biology, University of Glasgow, Weizmann Institute of Science, and Arttic Israel.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.